NCT05668637

Brief Summary

Invasive mechanical ventilation is one of the most important and life-saving therapies in the intensive care unit (ICU). In most severe cases, extracorporeal lung support is initiated when mechanical ventilation is insufficient. However, mechanical ventilation is recognised as potentially harmful, because inappropriate mechanical ventilation settings in ICU patients are associated with organ damage, contributing to disease burden. Studies revealed that mechanical ventilation is often not provided adequately despite clear evidence and guidelines. Variables at the ventilator and extracorporeal lung support device can be set automatically using optimization functions and clinical recommendations, but the handling of experts may still deviate from those settings depending upon the clinical characteristics of individual patients. Artificial intelligence can be used to learn from those deviations as well as the patient's condition in an attempt to improve the combination of settings and accomplish lung support with reduced risk of damage.

Trial Health

83
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
318,542

participants targeted

Target at P75+ for all trials

Timeline
4mo left

Started Jan 2023

Typical duration for all trials

Geographic Reach
5 countries

8 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Jan 2023Sep 2026

First Submitted

Initial submission to the registry

December 9, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

December 30, 2022

Completed
2 days until next milestone

Study Start

First participant enrolled

January 1, 2023

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

April 21, 2026

Status Verified

September 1, 2025

Enrollment Period

3.7 years

First QC Date

December 9, 2022

Last Update Submit

April 16, 2026

Conditions

Keywords

Mechanical ventilationventilator-induced lung injuryARDSartificial intelligence

Outcome Measures

Primary Outcomes (1)

  • Relative time of same device settings of the health care provider and the IntelliLung algorithm

    From date of intubation to date of extubation or date of discharge, which ever came first, assessed up to 12 month

Interventions

Decision support to optimise invasive mechanical ventilation settings

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Intensive care patients receiving invasive mechanical ventilation

You may qualify if:

  • Subjects who are 18 years or older and receive invasive mechanical ventilation for \> 4 hours

You may not qualify if:

  • Patients receiving one-lung ventilation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (8)

Cleveland Clinic Foundation, Cleveland, USA

Cleveland, Ohio, 44195, United States

RECRUITING

University Hospital Carl Gustav Carus Dresden

Dresden, Germany

RECRUITING

Institut Fur Angewandte Informatik (Infai) Ev

Leipzig, Germany

ACTIVE NOT RECRUITING

Institut Mihajlo Pupin

Belgrade, Serbia

ACTIVE NOT RECRUITING

Better Care Sl

Sabadell, Spain

ACTIVE NOT RECRUITING

Fundacio Parc Tauli

Sabadell, Spain

COMPLETED

Fundacion Publica Andaluza Progreso Y Salud

Seville, Spain

ACTIVE NOT RECRUITING

Inselspital, Universitätsspital Bern

Bern, Switzerland

COMPLETED

MeSH Terms

Conditions

Ventilator-Induced Lung Injury

Condition Hierarchy (Ancestors)

Lung InjuryLung DiseasesRespiratory Tract Diseases

Study Officials

  • Jakob Wittenstein, MD

    University Hospital Carl Gustav Carus at Technischen Universität Dresden, Germany

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jakob Wittenstein, MD

CONTACT

Thea Koch, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 9, 2022

First Posted

December 30, 2022

Study Start

January 1, 2023

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

April 21, 2026

Record last verified: 2025-09

Locations